Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
* Required Fields
Pay by invoice
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPT’s debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving accuracy and positive predictive value. Frost & Sullivan forecasts a quadruple increase in penetration for average-risk pregnancies in 2021. Scalable, automated in-lab workflow solutions and remote patient monitoring in pregnancy will effectively address the incoming volume and improve overall test economics. A significant proportion of consolidation is focused on the distribution and marketing of NIPTs to expand access and coverage, followed by product development and commercialization agreements. Frost & Sullivan envisages the trend in consolidation to increase in the coming age of distributable kits, offering new solutions to drive the expansion of testing to all autosomes and microdeletions. As the clinical application becomes widespread, major leaps forward are on the horizon, including sequencing-free optics-based technology and approaches that analyze whole-fetal cells instead of cfDNA. Expanded clinical application of NIPT will accelerate technological developments in the field, making the sector a viable market.Author: Amartya Bose
Kingdom of Saudi Arabia Paints & Coatings Growth Opportunities
Global Bio-based Coatings, Adhesives, and Sealants (CAS) Growth Opportunities
Global Fire Protection Coatings Growth Opportunities
Global 3D Printing Materials Growth Opportunities
Global Pharmaceutical Packaging Materials Growth Opportunities
Global Li-ion Battery Materials Growth Opportunities
Global Digital Health Solutions for Behavioral Health Management Growth Opportunities
Western European Protective Footwear Growth Opportunities
US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities
Global Infant Formula Ingredients Growth Opportunities
alternative energy market
digital signage market
consumer drone market
solar energy market
wound care market
smart wearables market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.